Drug Compatibility & Admixture Guidelines

Fleboflex containers have undergone extensive drug-container compatibility studies conducted by Grifols. These studies confirm stability and compatibility with a selected number of commonly used drug admixtures, making Fleboflex suitable for compounding in wellness and outpatient settings.

Validated drug compatibilities at refrigerated (5 degrees C) and room temperature (25 degrees C) include: Ondansetron (anti-nausea) stable for 10 days at both temperatures; Morphine stable for 10 days at both temperatures; Cyclophosphamide stable for 6 days refrigerated and 5 days at room temperature; and numerous other agents commonly used in outpatient infusion.

Critical rule: Compatibility of any additive with 0.9% Sodium Chloride MUST be verified before adding medication. Consult pharmacy references and manufacturer documentation. If discoloration, precipitates, insoluble complexes, or crystals appear after mixing, do NOT use the solution — discard immediately.

For wellness infusion protocols (vitamins, minerals, NAD+, glutathione, etc.), always verify that each additive is compatible with both the 0.9% NaCl solution AND the polypropylene container. While polypropylene has superior compatibility compared to PVC, individual drug interactions should always be confirmed.

Solutions containing additives should not be stored — prepare immediately before administration and discard any unused portion. This single-use approach aligns with Bridge clinical protocols for all outpatient infusion settings.